Quantcast

Latest Systemic scleroderma Stories

2009-07-16 08:00:00

DANVERS, Mass., July 16 /PRNewswire/ -- The Scleroderma Foundation, the nation's leading non-profit supporter of scleroderma research, is holding the Gateway to Hope 2009 National Patient Education Conference July 17-19, 2009 in St. Louis, Missouri. Scleroderma, an autoimmune disease without a known cure, affects an estimated 300,000 people in the U.S., making it as common as multiple sclerosis. Scleroderma causes collagen to build up in the tissues of the skin and in internal organs,...

2009-05-15 10:22:00

DANVERS, Mass., May 15 /PRNewswire/ -- The Scleroderma Foundation applauds Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI) for introducing H.R. 2408, the "Scleroderma Research and Awareness Act" in the House of Representatives today. This bipartisan legislation gives hope to the estimated 300,000 Americans and their families living with this devastating disease. Scleroderma is a chronic and disabling connective tissue disorder resulting from an overproduction of collagen. The word...

2008-10-24 09:00:06

DANVERS, Mass., Oct. 24 /PRNewswire/ -- The Scleroderma Foundation, in conjunction with leading rheumatologists and pulmonary hypertension specialists, today announced the launch of the ECHO educational campaign to raise awareness of the increased risk of developing pulmonary arterial hypertension (PAH) among scleroderma patients, and to encourage healthcare professionals to conduct annual echocardiograms to ensure that PAH is diagnosed and treated early. PAH is a rare, life-threatening...

2008-07-01 09:00:12

arGentis Pharmaceuticals, LLC announced today that it has filed a patent application for Nucleic Acid Sequences highly associated with the inability of oral immune tolerance to be induced in some systemic sclerosis (SSc) patients. As explained in the patent application, the identified sequences predict which patients can respond to ARG201, an immunotherapy that induces oral immune tolerance in patients with Late Phase diffuse cutaneous systemic sclerosis. Results from patient DNA samples...

2008-06-30 12:02:16

arGentis Pharmaceuticals, LLC announced today that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-reviewed rheumatology research journal. Systemic sclerosis is an autoimmune disease causing widespread fibrosis of the skin and internal organs. ARG201 is an immunotherapy that induces low...

2008-06-20 12:00:07

SOUTH SAN FRANCISCO, Calif. and ALLSCHWIL, Switzerland, June 20 /PRNewswire/ -- Actelion Ltd announced today that data published in The Lancet(1) show that, in mildly symptomatic pulmonary arterial hypertension (PAH) patients (WHO functional class II - WHO FC II), bosentan (Tracleer(R)) prevented clinical deterioration by significantly delaying time to clinical worsening and reduced the number of patients worsening to WHO FC III/IV. A significant reduction in pulmonary vascular resistance...

2007-04-13 06:00:14

By Park, Joo Hun; Kim, Dong Soon; Park, I-Nae; Jang, Se Jin; Et al Background: To investigate whether the better prognosis of interstitial pneumonias associated with collagen vascular disease (CVD) compared with idiopathic interstitial pneumonia (IIP) is due to higher frequency of the nonspecific interstitial pneumonia (NSIP) pattern in CVD, we compared the outcomes of patients from these two groups with the same histopathologic pattern. Subjects: The clinical features and survival of 362...

2005-06-29 06:38:13

Scleroderma's symptoms can range from hardened skin to damaged internal organs It's called scleroderma, a disfiguring disorder that causes the skin and internal organs to harden and tighten. Yet few people have heard of or know much about it. But that's not surprising, because medical experts have great gaps in their knowledge of the disease. There's no known cure for scleroderma, and although it's suspected to be an autoimmune disorder, doctors still debate its true cause. But experts agree...

2004-11-26 03:00:11

ABSTRACT: The purpose of this study was to identify hand factors that change over a five-year period that may be risk factors for the development of functional disability in persons with systemic sclerosis (scleroderma). Sixty individuals with scleroderma were administered assessments of grip and pinch strength, joint range of motion, and pain, and were observed for the presence of digital ulcers, digital scars, calcium deposits, puffy fingers, and tendon friction rubs. Matched-pairs chi...

2004-11-26 03:00:10

Cerebellar atrophy has been recognized as an occasional feature of systemic lupus erythematosus (SLE)1,2 but not systemic sclerosis. CASE HISTORY The patient was a woman whose illness had begun at the age of 40 with Raynaud's phenomenon, progressing to distal necrosis and ulceration of fingertips, with sclerosis of the hands, feet and face. The results of investigation were consistent with systemic sclerosis (SS). Subsequently she reported heartburn and regurgitation, and oesophageal...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related